ADD ANI AS A TRUSTED SOURCE
googleads
Menu
US

Pfizer starts Phase 2/3 clinical study to evaluate safety, efficacy of COVID-19 oral treatment in pediatric population

Washington [US], March 9 (ANI): Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate the safety and efficacy of its COVID-19 oral treatment in the pediatric population at risk of progression to severe disease.

ANI Mar 09, 2022 18:57 IST googleads

Representative image

Washington [US], March 9 (ANI): Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate the safety and efficacy of its COVID-19 oral treatment in the pediatric population at risk of progression to severe disease.
"Today, we announced the start of a Phase 2/3 study to evaluate the safety and efficacy of our COVID-19 oral treatment in pediatric participants at risk of progression to severe disease. We are eager to address the need for treatment in this important population," it said in a tweet.
The pharmaceutical company further said Pfizer's oral treatment is not approved but is authorized for emergency use by the Food and Drug Administration (FDA) to treat mild-to-moderate COVID-19 in high-risk patients 12 plus, weighing at least 40 kg, with positive results of SARS-CoV-2 viral testing. (ANI)

Get the App

What to Read Next

Asia

India consistently supported Maldives in crisis: Mohamed Nasheed

India consistently supported Maldives in crisis: Mohamed Nasheed

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Read More
Europe

ECO FAWN Society raises Pahalgam terror attack at UN Human Rights

ECO FAWN Society raises Pahalgam terror attack at UN Human Rights

At the 61st session of the United Nations Human Rights Council (UNHRC), Yasser Laaroussi, from the ECO FAWN Society, during General Debate under Item 3, in his oral statement, highlighted the terrorist attack that took place in Pahalgam on April 22, 2025. He urged the international community to intensify efforts to combat terrorism and ensure accountability for attacks targeting civilians

Read More
Asia

3 Indian seafarers dead in Gulf maritime incidents: Rajesh Sinha

3 Indian seafarers dead in Gulf maritime incidents: Rajesh Sinha

"There have been maritime incidents involving Indian crew on foreign-flagged vessels. Of these vessels, there were 78 Indian seafarers. Of these, 70 are unhurt and escaped. Four sustained injuries over the last few days, but are stable. Unfortunately, there have been three casualties, and one seafarer is missing," he said.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Asia

Pakistan’s outdated mandi system stifles agricultural innovation

Pakistan’s outdated mandi system stifles agricultural innovation

Pakistan's fruit and vegetable supply remains dominated by traditional middlemen and the "mandi" system, with digital platforms handling only 2-3% of trade. Restrictive provincial laws and lack of infrastructure force farmers into dependency on commission agents, stalling modern technological transformation in the agricultural sector.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.